Overview on Redox Medicine 2024

The 26th International Conference on Redox Medicine 2024, held on June 27-28, at Fondation Biermans-Lapôtre, Paris, France was a great success. Internation participants gathered and shared their latest research in the field of redox communication via more than 50 communications. The meeting highlighted the present and future of Redox Medicine.

Photo Gallery.

Redox Medicine 2024 Replay

In case you missed Redox Medicine 2024, Access to the conference replay is available for the period of 3 weeks. The replay includes all the 50+ communicationa presented during the conference. 

Redox Medicine 2024 Abstracts Book is Available

The abstracts book of Redox Medicine 2024 is now available. You can now gain access to the abstracts of over 50 communications highlighting the latest findings related to redox medicine.

Speakers of Redox Medicine 2024

Keynote Day 1 Redox Medicine: A Biologist Point of View  Miria Ricchetti, Institut Pasteur, France

Keynote Day 2 Lessons from a Journey along the Redox Chemistry of Nitrogen Oxides to Drug Development Bruce Freeman, University of Pittsburgh, USA

Antioxidants Stimulate Blood Flow in Tumors Martin O. Bergo, Karolinska Institutet, Sweden

Mechanism of the SuperInflammasome Complexes in Human Diseases and Redox Signaling Mario D. Cordero, Universidad Pablo de Olavide, Spain

Regulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral Dementia Christel Marquette, Laboratoire Biosanté U1292 INSERM-CEA-UGA, Equipe MAB2, France

Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent manner Zaher El Beck, Karolinska Institutet and Uppsala University, Sweden

Metabolic Regulation by Redox Signaling in the Heart Tamara Tomin, Technical University of Wien, Austria

The Reactive Species Interactome, Mitochondria, and the Gender-Brain Metabolism Nexus Laurent Chatre, ISTCT, CNRS, Université de Caen Normandie, France

NADH: The Redox Sensor in Aging-Related Disorders Roberta Rizzo, Università degli Studi di Ferrara, Italy

Redox Implications of Supplementary Oxygen during Major Abdominal Surgery Andrew Cumpstey, University of Southampton, United Kingdom

New Insights into the Impact of Oxidative Stress in Hypertensive Diseases of Pregnancy Daniel Vaiman, DR1 INSERM, Institut Cochin, France

Redox Medicine 2024: Biomarkers Carole Nicco, President of Redox Medicine Society

Identifying Oxidized Lipids in Neurodegenerative Diseases Sayuri Miyamoto, University of São Paulo, Brazil

Exploring Predictors of HDL Oxidative Stress Functionality in Post-Covid Disease and Relation to Severity Jumana Saleh, Sultan Qaboos University, Oman

Redox, Radiotherapy and Biomarkers Radia Tamarat, Institut de Radioprotection et de Sûreté Nucléaire (IRSN), France

Targeting the Keap1/Nrf2 Pathway for Treatment of Chronic Neurodegenerative Diseases Jeffrey A. Johnson, University of Wisconsin, USA

Drug repurposing on Alzheimer's Disease & NRF2 Modulation  George M. Spyrou, The Cyprus Institute of Neurology & Genetics, Cyprus

Pharma’s Search for Redox-Modulating Therapeutics Duncan Emerton, Vice-President of Citeline, United Kingdom

How to Develop a Drug – From Preclinical to Clinical Antonio Vila-Coro, IQVIA, Spain

Artificial Intelligence in NeuroInflammation, Biomarkers and Redox Medicine Stéphane Mouchabac, CHU St Antoine DMU Neurosciences and Institut du Cerveau, Paris

Artificial Intelligence & Algorithms: Applications in Redox Medicine & Radiology Maxime Barat, Université Paris Cité, Hôpital Cochin, France

Redox Medicine 2024 Attendees

Redox Medicine 2024 Highlights